News
Seventy per cent of participant enrolment has been completed for the Phase III clinical trial of indigenous one-shot dengue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback